🔎 Trials Near Me

Home › Leucemia mieloide acuta › New Jersey › Edison

Studi clinici su Leucemia mieloide acuta a Edison, NJ

20 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Edison e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.

Testo ufficiale dello studio (inglese)

Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

In reclutamentoFase 1
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Età da 18 a 59 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

In reclutamentoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06317649

A Study of CRD3874-SI in People With Leukemia

In reclutamentoFase 1
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07661095

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

In reclutamentoFase 2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Età da 18 a 59 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT05554406

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

In reclutamentoFase 3
  • Saint Peter's University Hospital, New Brunswick · a 3 mi di distanza
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · a 3 mi di distanza
6 Months – 21 Years · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04293562

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

In reclutamentoFase 1/2
  • Saint Peter's University Hospital, New Brunswick · a 3 mi di distanza
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · a 3 mi di distanza
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

In reclutamentoFase 3
  • Rutgers Biomedical and Health Sciences, New Brunswick · a 3 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07007312

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

In reclutamentoFase 2
  • Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi di distanza
Età 60 e oltre · Tutti i sessi · Aggiornato il 17 lug 2026 · NCT07392242

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

In reclutamentoStudio osservazionale
  • Robert Wood Johnson/Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

In reclutamentoFase 1
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT05756777

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

In reclutamentoFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi di distanza
Età 1 e oltre · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT06017258

A Study of Revumenib and Mezigdomide in People With Leukemia

In reclutamentoFase 1/2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi di distanza
Età 12 e oltre · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT07356154

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

In reclutamentoFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi di distanza
Età da 18 a 70 · Tutti i sessi · Aggiornato il 17 giu 2026 · NCT07011004

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

In reclutamentoFase 1/2
  • Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi di distanza
Età 12 e oltre · Tutti i sessi · Aggiornato il 24 mar 2026 · NCT04988555

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

In reclutamentoFase 1
  • Rutgers Cancer Institute, New Brunswick · a 3 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mar 2026 · NCT05735184

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

In reclutamentoFase 1
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 mar 2026 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

In reclutamentoFase 2
  • Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi di distanza
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 feb 2026 · NCT06773208

Studi su Leucemia mieloide acuta in altre città

Altri studi a Edison

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.